Resources from the same session
Where are we going with OC? Evolving the management of 1L advanced ovarian cancer with PARPis
Presenter: Iain McNeish
Session: GSK - Shifting the treatment paradigm of OC/EC: Towards a new horizon
Resources:
Webcast
Where are we going with EC? Aiming to improve outcomes in primary advanced or recurrent endometrial cancer with PD-(L)1 inhibitors
Presenter: Ainhoa Madariaga Urrutia
Session: GSK - Shifting the treatment paradigm of OC/EC: Towards a new horizon
Resources:
Webcast
Live Q&A and discussion
Presenter: All Speakers
Session: GSK - Shifting the treatment paradigm of OC/EC: Towards a new horizon
Resources:
Webcast